79.00
Schlusskurs vom Vortag:
$85.10
Offen:
$83.84
24-Stunden-Volumen:
349.68K
Relative Volume:
0.52
Marktkapitalisierung:
$2.32B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-25.40
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
-3.84%
1M Leistung:
-13.03%
6M Leistung:
-36.38%
1J Leistung:
-14.36%
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
WGS
Genedx Holdings Corp
|
79.05 | 2.49B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
476.98 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
189.24 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.00 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.15 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
289.14 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Discipline and Rules-Based Execution in WGS Response - Stock Traders Daily
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons By Investing.com - Investing.com South Africa
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons - Investing.com
AI Stocks: What is the Moat Score of GeneDx Holdings Corp2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
$80,000 per child: gene tests shift kids from ER to planned care - Stock Titan
Why Is Zevra Therapeutics Stock Trading Higher Today? - Bitget
GeneDx (NASDAQ:WGS) Trading Down 5.6%Time to Sell? - MarketBeat
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
GeneDx Holdings Corp. to Launch Genetic Testing Program with Zevra Therapeutics, Inc. to Support Patients with Suspected Niemann-Pick Disease Type C - marketscreener.com
Eligible Niemann-Pick C patients get faster genetic tests at no charge - Stock Titan
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments - Yahoo Finance
Genedx Earnings Call Signals Strong Genomics Growth - TipRanks
Aug Drivers: What are the risks of holding GeneDx Holdings Corp2026 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
GeneDx CFO Feeley sells $486k in shares - Investing.com Nigeria
Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to Trade - Finviz
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership - Business Wire
Setup Watch: Is GeneDx Holdings Corp Equity Warrant a stock for growth or value investors2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Aug Mood: What are the risks of holding GeneDx Holdings Corp2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
GeneDx Holdings Inc. Stock Rises Amid Strong Q4 Results and Market Expansions - timothysykes.com
Setup Watch: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stockQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading Action: Can GeneDx Holdings Corp Equity Warrant continue delivering strong returns2025 Stock Rankings & Long Hold Capital Preservation Tips - baoquankhu1.vn
Energy Moves: Can GeneDx Holdings Corp deliver alphaJobs Report & Free Long-Term Investment Growth Plans - baoquankhu1.vn
GeneDx Achieves Strong Q4 Growth Amid Positive Outlook for 2026 - StocksToTrade
GeneDx Stock Climbs After Strong Q4 Results and Bullish 2026 Guidance - timothysykes.com
GeneDx Rides Fiscal Gains with Bright 2026 Forecast - StocksToTrade
GeneDx (WGS) Outperforms With Strong Quarter Results, Positive Earnings Outlook Draws Focus - timothysykes.com
GeneDx Stock Soars Following Strong Q4 Results and Updated 2026 Guidance - StocksToTrade
Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Steven A. Cohen, Warren Buffett, Scott Bessent, Sabal Capital Management, Point72 Asset Management, GeneDx Holdings Corp (WGS), DXP Enterprises Inc (DXPE), and More - Insider Monkey
Market Review: Is GeneDx Holdings Corp Equity Warrant showing insider buyingSwing Trade & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Keith Meister Purchases 140,026 Shares of GeneDx (NASDAQ:WGS) Stock - MarketBeat
Insider Buying: GeneDx (NASDAQ:WGS) Director Buys 29,495 Shares of Stock - MarketBeat
GeneDx CFO Feeley sells $486k in shares By Investing.com - Investing.com UK
Corvex management buys GeneDx (WGS) shares worth $13.4 million By Investing.com - Investing.com India
Corvex management buys GeneDx (WGS) shares worth $13.4 million - Investing.com
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 25,459 Shares - MarketBeat
GeneDx (NASDAQ:WGS) CFO Sells $486,360.07 in Stock - MarketBeat
ARK Investment Management LLC Purchases New Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Amova Asset Management Americas Inc. Invests $31.44 Million in GeneDx Holdings Corp. $WGS - MarketBeat
New Blackstone Loan And Refinancing Might Change The Case For Investing In GeneDx Holdings (WGS) - simplywall.st
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - Business Wire
GeneDx Shares Rise 7.2% After Analyst Updates - National Today
Tax-driven stock sale by GeneDx (WGS) CFO after RSU vest - Stock Titan
GeneDx (NASDAQ:WGS) Shares Up 7.2%Should You Buy? - MarketBeat
Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround - Finviz
Down 25% Over the Past Month, Here’s Why GENEDX HOLDINGS (WGS) May Be Poised for a Rebound - Bitget
GeneDx Secures New $100 Million Term Loan Facility - The Globe and Mail
GeneDx (NASDAQ:WGS) Trading Down 6.6%Should You Sell? - MarketBeat
GeneDx Secures $100 Million Five-Year Term Loan From Blackstone to Refinance Debt - TradingView
Genedx Holdings Corp. Enters into $100 Million Loan Agreement with Blackstone to Repay Existing Credit Agreement and Optimize Balance Sheet - marketscreener.com
GeneDx (NASDAQ: WGS) adds $100M secured term loan from Blackstone lenders - Stock Titan
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Genedx Holdings Corp-Aktie (WGS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Meister Keith A. | Director |
Mar 03 '26 |
Buy |
70.89 |
29,495 |
2,090,937 |
3,088,124 |
| Feeley Kevin | CHIEF FINANCIAL OFFICER |
Mar 04 '26 |
Sale |
78.61 |
6,187 |
486,370 |
18,674 |
| Stueland Katherine | CHIEF EXECUTIVE OFFICER |
Mar 04 '26 |
Sale |
78.61 |
25,459 |
2,001,371 |
38,683 |
| Dechairo Bryan | Chief Operating Officer |
Feb 04 '26 |
Sale |
85.70 |
5,961 |
510,874 |
0 |
| Dechairo Bryan | Chief Operating Officer |
Feb 01 '26 |
Option Exercise |
0.00 |
9,374 |
0 |
9,374 |
| Dechairo Bryan | Chief Operating Officer |
Feb 02 '26 |
Sale |
99.53 |
3,413 |
339,682 |
5,961 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):